281 related articles for article (PubMed ID: 11245433)
1. Modulation of nucleotide excision repair capacity by XPD polymorphisms in lung cancer patients.
Spitz MR; Wu X; Wang Y; Wang LE; Shete S; Amos CI; Guo Z; Lei L; Mohrenweiser H; Wei Q
Cancer Res; 2001 Feb; 61(4):1354-7. PubMed ID: 11245433
[TBL] [Abstract][Full Text] [Related]
2. [Association of genetic polymorphisms in the DNA repair gene XPD with risk of lung and esophageal cancer in a Chinese population in Beijing].
Xing DY; Qi J; Tan W; Miao XP; Liang G; Yu CY; Lu WF; Zhou CN; Wu M; Lin DX
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Feb; 20(1):35-8. PubMed ID: 12579497
[TBL] [Abstract][Full Text] [Related]
3. Association of the DNA repair gene XPD Asp312Asn polymorphism with p53 gene mutations in tobacco-related non-small cell lung cancer.
Gao WM; Romkes M; Day RD; Siegfried JM; Luketich JD; Mady HH; Melhem MF; Keohavong P
Carcinogenesis; 2003 Oct; 24(10):1671-6. PubMed ID: 12844488
[TBL] [Abstract][Full Text] [Related]
4. Reduced DNA repair of benzo[a]pyrene diol epoxide-induced adducts and common XPD polymorphisms in breast cancer patients.
Shi Q; Wang LE; Bondy ML; Brewster A; Singletary SE; Wei Q
Carcinogenesis; 2004 Sep; 25(9):1695-700. PubMed ID: 15090466
[TBL] [Abstract][Full Text] [Related]
5. Polymorphisms in XPD exons 10 and 23 and bladder cancer risk.
Schabath MB; Delclos GL; Grossman HB; Wang Y; Lerner SP; Chamberlain RM; Spitz MR; Wu X
Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):878-84. PubMed ID: 15824159
[TBL] [Abstract][Full Text] [Related]
6. Specific combinations of DNA repair gene variants and increased risk for non-small cell lung cancer.
Popanda O; Schattenberg T; Phong CT; Butkiewicz D; Risch A; Edler L; Kayser K; Dienemann H; Schulz V; Drings P; Bartsch H; Schmezer P
Carcinogenesis; 2004 Dec; 25(12):2433-41. PubMed ID: 15333465
[TBL] [Abstract][Full Text] [Related]
7. Polymorphisms in base-excision repair and nucleotide-excision repair genes in relation to lung cancer risk.
De Ruyck K; Szaumkessel M; De Rudder I; Dehoorne A; Vral A; Claes K; Velghe A; Van Meerbeeck J; Thierens H
Mutat Res; 2007 Jul; 631(2):101-10. PubMed ID: 17531525
[TBL] [Abstract][Full Text] [Related]
8. Polymorphisms in the DNA repair genes XRCC1 and ERCC2, smoking, and lung cancer risk.
Zhou W; Liu G; Miller DP; Thurston SW; Xu LL; Wain JC; Lynch TJ; Su L; Christiani DC
Cancer Epidemiol Biomarkers Prev; 2003 Apr; 12(4):359-65. PubMed ID: 12692111
[TBL] [Abstract][Full Text] [Related]
9. Polymorphisms of the DNA repair genes XRCC1, XRCC3, XPD, interaction with environmental exposures, and bladder cancer risk in a case-control study in northern Italy.
Shen M; Hung RJ; Brennan P; Malaveille C; Donato F; Placidi D; Carta A; Hautefeuille A; Boffetta P; Porru S
Cancer Epidemiol Biomarkers Prev; 2003 Nov; 12(11 Pt 1):1234-40. PubMed ID: 14652287
[TBL] [Abstract][Full Text] [Related]
10. Polymorphisms in DNA repair genes, chromosome aberrations, and lung cancer.
Harms C; Salama SA; Sierra-Torres CH; Cajas-Salazar N; Au WW
Environ Mol Mutagen; 2004; 44(1):74-82. PubMed ID: 15199549
[TBL] [Abstract][Full Text] [Related]
11. DNA repair gene XPD polymorphism and lung cancer risk: a meta-analysis.
Hu Z; Wei Q; Wang X; Shen H
Lung Cancer; 2004 Oct; 46(1):1-10. PubMed ID: 15364127
[TBL] [Abstract][Full Text] [Related]
12. Gene-environment interaction for the ERCC2 polymorphisms and cumulative cigarette smoking exposure in lung cancer.
Zhou W; Liu G; Miller DP; Thurston SW; Xu LL; Wain JC; Lynch TJ; Su L; Christiani DC
Cancer Res; 2002 Mar; 62(5):1377-81. PubMed ID: 11888908
[TBL] [Abstract][Full Text] [Related]
13. Polymorphisms in the DNA repair genes XPC, XPD, and XPG and risk of cutaneous melanoma: a case-control analysis.
Li C; Hu Z; Liu Z; Wang LE; Strom SS; Gershenwald JE; Lee JE; Ross MI; Mansfield PF; Cormier JN; Prieto VG; Duvic M; Grimm EA; Wei Q
Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2526-32. PubMed ID: 17164380
[TBL] [Abstract][Full Text] [Related]
14. XPD codon 751 polymorphism, metabolism genes, smoking, and bladder cancer risk.
Stern MC; Johnson LR; Bell DA; Taylor JA
Cancer Epidemiol Biomarkers Prev; 2002 Oct; 11(10 Pt 1):1004-11. PubMed ID: 12376500
[TBL] [Abstract][Full Text] [Related]
15. Polymorphisms in the two helicases ERCC2/XPD and ERCC3/XPB of the transcription factor IIH complex and risk of lung cancer: a case-control analysis in a Chinese population.
Hu Z; Xu L; Shao M; Yuan J; Wang Y; Wang F; Yuan W; Qian J; Ma H; Wang Y; Liu H; Chen W; Yang L; Jing G; Huo X; Chen F; Jin L; Wei Q; Wu T; Lu D; Huang W; Shen H
Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1336-40. PubMed ID: 16835333
[TBL] [Abstract][Full Text] [Related]
16. Polymorphisms in XPD and TP53 and mutation in human lung cancer.
Mechanic LE; Marrogi AJ; Welsh JA; Bowman ED; Khan MA; Enewold L; Zheng YL; Chanock S; Shields PG; Harris CC
Carcinogenesis; 2005 Mar; 26(3):597-604. PubMed ID: 15564288
[TBL] [Abstract][Full Text] [Related]
17. Polymorphisms in the DNA repair gene XPD and susceptibility to esophageal squamous cell carcinoma.
Yu HP; Wang XL; Sun X; Su YH; Wang YJ; Lu B; Shi LY; Xiong CL; Li YY; Li F; Xu SQ
Cancer Genet Cytogenet; 2004 Oct; 154(1):10-5. PubMed ID: 15381366
[TBL] [Abstract][Full Text] [Related]
18. XRCC1 and XPD polymorphisms and esophageal adenocarcinoma risk.
Liu G; Zhou W; Yeap BY; Su L; Wain JC; Poneros JM; Nishioka NS; Lynch TJ; Christiani DC
Carcinogenesis; 2007 Jun; 28(6):1254-8. PubMed ID: 17264068
[TBL] [Abstract][Full Text] [Related]
19. Association of polymorphisms in the cyclin D1 and XPD genes and susceptibility to cancers of the upper aero-digestive tract.
Buch S; Zhu B; Davis AG; Odom D; Siegfried JM; Grandis JR; Romkes M
Mol Carcinog; 2005 Apr; 42(4):222-8. PubMed ID: 15754315
[TBL] [Abstract][Full Text] [Related]
20. Relationship between XPG codon 1104 polymorphism and risk of primary lung cancer.
Jeon HS; Kim KM; Park SH; Lee SY; Choi JE; Lee GY; Kam S; Park RW; Kim IS; Kim CH; Jung TH; Park JY
Carcinogenesis; 2003 Oct; 24(10):1677-81. PubMed ID: 12869423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]